Decoy Therapeutics (DCOY) Return on Sales (2016 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Return on Sales of 0.31% for Q1 2022, down 29.0% year-over-year from 0.44% in Q1 2021, and down 302.12% quarter-over-quarter from 0.08% in Q4 2021.
Decoy Therapeutics (DCOY) Return on Sales (2016 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Return on Sales for 7 consecutive years, with 0.31% the latest figure, recorded in Q1 2022.
- In Q1 2022, Return on Sales fell 29.0% year-over-year to 0.31%; the TTM figure through Mar 2022 stood at 0.31% (down 30.0% YoY), while the FY2021 annual figure was 0.1%, down 8.0% from the prior year.
- Return on Sales retreated to 0.31% in Q1 2022 per DCOY's latest filing, from 0.08% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q3 2019 and bottomed at 0.63% in Q1 2018.
- Historically, Return on Sales has averaged 0.13% across 5 years, with a median of 0.02% in 2019.
- Annual changes were most pronounced in 2018 — Return on Sales surged 110 bps — and 2022, when it declined 29 bps.
- Decoy Therapeutics' Return on Sales stood at 0.19% in 2018, then surged by 100 bps to 0.0% in 2019, then slumped by 239835 bps to 0.01% in 2020, then tumbled by 548 bps to 0.08% in 2021, then plunged by 302 bps to 0.31% in 2022.
- Business Quant data shows DCOY's Return on Sales at 0.31% in Q1 2022, 0.08% in Q4 2021, and 0.04% in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.00% |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - | -0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12% |
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.04% |
| Jun 30, 2021 | -0.06% |
| Mar 31, 2021 | -0.02% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | -0.02% |
| Mar 31, 2020 | -0.02% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | -0.01% |
| Mar 31, 2019 | -0.02% |
| Dec 31, 2018 | -0.19% |
| Sep 30, 2018 | -0.49% |
| Jun 30, 2018 | -0.37% |
| Mar 31, 2018 | -0.63% |
| Dec 31, 2017 | -1.30% |
| Sep 30, 2017 | -0.25% |